诺和诺德首席执行官：2026年业绩指引的原因“实际上与价格下跌有关”。

Core Insights - The CEO of Novo Nordisk indicated that the guidance for 2026 performance is primarily related to price declines [1] Group 1 - The company's performance outlook for 2026 is influenced by pricing pressures in the market [1]